<DOC>
	<DOCNO>NCT00889486</DOCNO>
	<brief_summary>The purpose study evaluate effect TZP-102 gastric empty rate , gastroparesis symptom health-related quality life diabetic patient gastroparesis .</brief_summary>
	<brief_title>Safety Efficacy Once-daily Oral Administrations TZP-102 Gastroparesis Patients With Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<criteria>18 80 year age , inclusive . Type 1 type 2 diabetes mellitus . Female patient childbearing potential must negative serum pregnancy test use ( agree continue use throughout study ) acceptable method contraception . HbA1c level less than/equal 10.0 % Screening Visit . Diagnosis gastroparesis include ( three follow requirement apply ) : i. Documented delayed gastric emptying ; ii . A great 3 month history symptom gastroparesis ; iii . A GCSI Total Score great than/equal 2.66 Screening Visit great than/equal 1.90 Day 1 visit . Upper gastrointestinal obstruction rule endoscopy barium scan . Concomitant medication must stable least 2 week lead Baseline Visit maintain study . Body Mass Index ( BMI ) &lt; 35 . Delayed gastric empty breath test demonstrate Baseline Visit . Persistent daily vomit Gastrectomy , obesity surgery , fundoplication , vagotomy/pyloroplasty . Pyloric Botox within 6 month prior Screening Visit . NG , PEG PEJ feed tube . Required inpatient hospitalization treatment gastroparesis within 2 week prior Screening Visit . Parenteral nutrition treatment gastroparesis within 2 month prior Screening Visit . Active gastric pacemaker within 3 month prior Screening Visit . Participation investigational study within 30 day prior study entry . Chronic severe diarrhea . Diabetic ketoacidosis require hospitalization within 30 day prior study entry . History eat disorder within 2 year prior study entry . Significant chronic obstructive pulmonary disease chronic asthma . Patient heavy smoker , and/or unable unwilling abstain smoking three study visit gastric empty breath test perform . History risk factor Torsades de Pointes . Patient require treatment certain concomitant medication know clinically recognize risk Torsades de Pointes . History acute myocardial infarction ( MI ) unstable angina within 12 month prior study entry . History psychiatric disorder cognitive impairment would interfere participation study . History alcohol dependency within 2 year prior study entry . Taking opiates abdominal pain . History HIV infection . History Hepatitis B C currently exhibit symptom expect worsen course study . Requires dialysis severely impaired renal function . Severe impairment liver function . Uncontrolled hypo hyperthyroidism . History adrenal insufficiency . Pregnant breastfeeding . Allergic intolerant wheat , egg , soy milk product . Patient require glutenfree diet . Any medical condition social circumstance , investigator 's opinion , make inappropriate patient participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>gastroparesis</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>delay gastric empty</keyword>
</DOC>